started · updated
UK watchdog bans weight-loss pill advertisements
The Advertising Standards Authority (ASA) has banned several advertisements for promoting prescription-only weight-loss medicines to the public. The rulings targeted companies including Voy, Juniper, and MedExpress.
Voy faced bans for a London bus advertisement and a video-on-demand campaign. Although the ads included small print referring to a glucomannan food supplement, the ASA determined the imagery and wording were likely to lead consumers to believe they were advertising the newly licensed oral Wegovy tablets, which are prescription-only.
Additionally, the ASA banned a YouTube advertisement from Juniper and an Instagram advertisement from MedExpress. The MedExpress ad used phrases such as “New weight loss tablets” and “No needles” while inviting users to join a waitlist. The watchdog emphasized that advertisers must consider the overall impression created by their campaigns, noting that medicines do not need to be named directly to be understood as prescription-only products.
Entities
Advertising Standards Authority · Juniper · MedExpress · Voy · Wegovy